Top
US_Flag An official website of the United States government Here's how you know
GOV

The .gov means it's official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

LOCK

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

 
U.S. Food & Drug Administration
Continuing Education and Accreditation
Division of Learning and Organizational Development
Center for Drug Evaluation and Research

Q&A with FDA Podcast: Conversation on Paxlovid with Dr. John Farley

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Fri, 3/1/24: 12:00 AM EST
Ends On: Sun, 2/28/27: 12:00 AM EST
Type: Enduring Material
Credits: 0.5
Description: This enduring material focuses on providing useful information to help health care providers in decision making regarding Paxlovid, authorized under an emergency use authorization. The discussion includes how to assess a patient for high risk progression to severe COVID-19, pharmacists' and other health care providers' role, the information needed when prescribing Paxlovid, and resources to help prescribers assess patient eligibility.
Objectives:
  • Discuss who can prescribe Paxlovid and how to assess a patient’s eligibility for Paxlovid under an EUA.
  • Describe Pharmacist’s role, limitations, and the resources available to prescribe Paxlovid.
Additional Information: Review the Activity Announcement for additional details: Announcement Form